How TLR4 Protects Against Mild Leptospirosis

Jenn Hoskins
1st June, 2025

How TLR4 Protects Against Mild Leptospirosis

Both TLR4-competent and hyporesponsive mouse strains exhibited significant weight loss (a–c) and bacterial dissemination in blood (d) and urine (e) following infection with Leptospira interrogans serovar Copenhageni, supporting the suitability of these strains as models for sublethal leptospirosis.

Image adapted from: Abil et al. / CC BY (Source)

Key Findings

  • At the University of Tennessee Health Science Center, researchers using mouse models found that mice with normal and weakened TLR4 receptors both developed mild leptospirosis
  • Both groups showed similar weight loss, bacterial levels, and antibody responses, suggesting that factors besides TLR4 alone shape the disease’s course
[1] Researchers at the University of Tennessee Health Science Center and Yale University School of Medicine have recently investigated the role of a key immune receptor in mouse models of sublethal leptospirosis, a disease caused by pathogenic Leptospira bacteria. Leptospirosis is an emerging health concern transmitted from animals to humans, typically through exposure to contaminated water or soil. In severe cases, it can lead to significant organ damage. Historically, animal models, including hamsters and rats, have been used to study various aspects of the disease. More recent efforts have focused on mice, due to their versatile genetic tools and available transgenic lines. Yet, a question has remained: are mice with a normally functioning immune receptor, known as TLR4, any different in their response to leptospiral infection compared to those with a compromised version of this receptor? This study compared two groups of mice: one group with a fully competent TLR4 function (strains C3H/HeN and C57BL/6) and another group with a hyporesponsive (or less active) TLR4 gene (strain C3H/HeJ). TLR4 is a protein that plays an important role in the immune system, helping cells recognize and respond to pathogens. Previous work has shown that mice with a mutated or less effective TLR4 appear to have altered responses to bacterial infections. In the context of leptospirosis, a sublethal infection model means that while the mice do not die from the infection, they still show clinical and molecular signs of disease. The researchers infected all three strains of mice with Leptospira interrogans serovar Copenhageni strain Fiocruz L1-130 and monitored them over a period of two weeks. They measured various indicators of infection and illness including weight loss, survival, levels of bacterial RNA in blood and urine, and the burden of viable bacteria in the kidneys. These measurements were compared with those from uninfected control mice to evaluate the impact of the infection. The study revealed that while all strains developed signs of the disease, the mice with competent TLR4 receptors did not exhibit significantly different outcomes compared to the TLR4-hyporesponsive mice. One of the key findings was that the differences between the immune responses of the TLR4-competent strains (C3H/HeN and C57BL/6) and the TLR4-hyporesponsive strain (C3H/HeJ) were not marked enough to suggest increased susceptibility to leptospirosis in one group over the other. Clinical signs such as weight loss and other measurements, including the levels of leptospiral 16S rRNA—a molecule used to identify and quantify the bacteria—in both blood and urine, showed only modest differences. These results indicate that having a fully functioning TLR4 is not alone sufficient to significantly alter the severity of the disease in these mouse models. Further analysis of the immune response involved looking at the levels of immunoglobulins—proteins produced by the immune system to fight infections. The study measured IgM, the first antibody produced in response to an infection, and IgG3, a subclass of antibodies associated with long-term immune responses. In all three mouse strains, there was an increase in both IgM and IgG3 following infection, coupled with a general absence of inflammatory markers at two weeks post infection. The lack of strong inflammatory signals suggests that the immune systems of the mice were managing the infection without causing excessive tissue damage, a common complication seen in more severe infections. The findings of this study provide important insight into the suitability of mouse models for studying leptospirosis. For many years, studies using mice were sometimes questioned because mice were thought to be less susceptible to lethal infection[2]. Past research using various strains indicated that while certain mouse lines developed specific kidney lesions and maintained high levels of the bacteria in their kidneys, they did not display high mortality rates. Some strains, like those in earlier studies, even showed variability in their resistance to subclinical forms of the disease[3]. This current research builds upon those earlier findings by demonstrating that even mice with fully functional TLR4 receptors can manifest sublethal infection that is comparable to that in immunocompromised mice. The new study not only bridges gaps left by prior research but also expands the potential for using genetically modified mice to explore immune responses in leptospirosis. With TLR4 no longer seen as a sole factor influencing disease susceptibility, researchers can now use models such as C3H/HeN and C57BL/6 to further dissect the complex interactions between the immune system and leptospiral bacteria. This could lead to the identification of new targets for therapeutic intervention or vaccine development, addressing issues that have long been a challenge due to the lack of effective vaccines for leptospirosis and the difficulty of genetically manipulating Leptospira. In summary, the study shows that mouse strains with a competent TLR4 receptor are equally appropriate as models for sublethal leptospirosis when compared with the hyporesponsive strain. This advances our understanding of how the host’s innate immune system handles infection and reinforces the value of mouse models—already a foundation in previous leptospirosis research[2][3]—for future investigations. By refining these models, scientists can better explore the mechanisms of protective immunity and inflammation in leptospirosis, potentially paving the way for new treatment strategies in this economically and clinically significant disease.

MedicineAnimal Science

References

Main Study

1) TLR4 competence and mouse models of sublethal leptospirosis

Published 30th May, 2025

https://doi.org/10.1371/journal.pntd.0013163

Related Studies

2) Animal Models of Leptospirosis: Of Mice and Hamsters.

https://doi.org/10.3389/fimmu.2017.00058

3) Different outcomes of experimental leptospiral infection in mouse strains with distinct genotypes.

https://doi.org/10.1099/jmm.0.021089-0


Related Articles

An unhandled error has occurred. Reload 🗙